HeyJaredWilling to Win
Biotech Leaders Against All OddsBiotech leaders, founders and executives are warriors chasing cures against impossible odds. Their journeys are not only about science, but about belief, resilience, and leadership.
- Indexed episodes, last 90 days
- 7
- Latest publication
- Sep 17, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 21, 2026
Latest episodes
Episode 22 | So, Do We Have a Deal? (Achim Plum, HTGF) (opens the original)
Read excerpt
Achim Plum spent 25 years on the operator side of biotech. Two IPOs, one of them closed on the last day of the roadshow, sitting at a Zurich breakfast with no idea whether the book would fill by evening. His last company died on the science itself. He says: "I did every possible mistake one could do. I survived them mostly." Then he switched sides. Since January 2025 he runs HTGF, Germany's most active seed investor, as the Managing Director heading Life Science and Chemistry. Around 400 compani
Episode 21 | I Shouldn't Be Here: Moderna's First CSO on Making Life Count (Antonin de Fougerolles) (opens the original)
Read excerpt
Tony de Fougerolles was born in Montreal three months premature, weighing about a pound and a half. He was the youngest child in Canada to survive at that age and weight. Twenty years of operations followed: doctors two or three times a week, surgery every summer, every Christmas. Ask him what he would change, and he says: nothing. "I shouldn't be here. This is all extra, let's make the most of it." He picked science because it was his worst subject. He joined Alnylam when it was six people in o
Episode 20 | I Can't Not Be Fascinated (Wolfgang Hofmann) (opens the original)
Read excerpt
As a child, Wolfgang Hofmann was more often sick in bed than in school, his asthma so severe that a doctor told his parents he would probably not survive. Ask him about it today, and he gives you one sentence on resilience. Then he talks about curiosity. That is the pattern of this whole conversation. The engine of his career is not the illness. It is fascination, and the people who passed it on: a Harvard professor who ran a thousand mutations when everyone said it would never work. A thesis ad
Episode 19 | We understand only 8 % of Biology (Karol Jarzabek) (opens the original)
Read excerpt
Eight percent of drugs make it to approval. Karol Jarzabek thinks that is roughly how much we understand about biology as a civilization, and he thinks the real number is lower.He also thinks he knows why. The best minds in the field spend three quarters of their time at a bench, and most of that work is work they have already done once.This is a conversation about what a person does with a number like that.Karol grew up as an immigrant kid who never followed the rules. He was told for years tha
Episode 18 | Turning down the obvious path (Rosario "Charo" Cestau Murphy) (opens the original)
Read excerpt
Halfway through her career, Rosario "Charo" Cestau Murphy did the thing nobody advises. She left a global role in Boston and moved to Latin America for a job that was smaller on paper. Her own words for the move: "I call this going from the Pentagon to the trenches." In this episode, Christian Rados sits down with Charo for a conversation about the decisions that do not show up well on a CV. About arriving in Buenos Aires with an affiliate to build, a home still to find, and a pregnancy nobody h
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.